Drs. Vivian Bykerk, Lionel B. Ivashkiv, and Alessandra B. Pernis of the Division of Rheumatology will serve as key researchers in one of the 11 research groups across the United States that comprise the NIH Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus) Network. Rheumatoid Arthritis and Lupus, which can be devastating, are relatively common and severe autoimmune diseases.
Dr. Vivian Bykerk, on staff at the Hospital for Special Surgery (HSS) and an Associate Professor of Medicine (Department of Medicine) at Weill Cornell, presented advances in arthritis research at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professions. The message of the new findings was: Delaying treatment for rheumatoid arthritis can greatly increase the likelihood of worse function at two years.
The Fellows Research Award is presented annually to fellows within the Department of Medicine who have presented outstanding research.
Mary K. Crow, M.D., has been appointed Chief of the Division of Rheumatology in the Department of Medicine. She has been concurrently appointed Physician-In-Chief and Chair of the Division of Rheumatology at the Hospital for Special Surgery (HSS). Dr. Crow is an internationally recognized investigator and a leader in the field of rheumatology and autoimmunity research and clinical practice.
Initiated in 2002, this award is presented annually to fellows within the Department of Medicine who have presented outstanding research.
The AAP, founded in 1885, annually recognizes 55 individuals who have attained preeminence in medical research. Elected members have included Nobel laureates and members of the National Academy of Science, and encompass all field of medicine.